Hos levertransplanterede patienter var MPA- AUC- værdierne efter i. v. administration af CellCept (1 g to gange daglig) efterfulgt af 1, 5 g to gange daglig oralt sammenlignelige med værdierne hos nyretransplanterede patienter, der fik oral CellCept (1 g CellCept to gange daglig).
In hepatic transplant patients, administration of 1 g BID intravenous CellCept followed by 1.5 g BID oral CellCept resulted in MPA AUC values similar to those found in renal transplant patients administered 1 g CellCept BID.